STOCKS CLIMB: Here's what you need to know
Ker Robertson / Staff / Getty Images
All three major indices ticked up into the green to varying degrees.
Stocks saw their biggest declines in eight months on Wednesday following a report that President Donald Trump in February asked James Comey, the FBI director whom he fired last week, to drop an investigation into former National Security Adviser Michael Flynn.
First up, the scoreboard:
- Dow: 20,696.01, +89.08, (+0.43%)
- S&P 500: 2,370.27, +13.31, (0.56%)
- Nasdaq: 6,066.80, +54.33, (0.90%)
- US 10-year yield: 2.226%, +0.010
- WTI crude: $49.33, +0.27, (+0.55%)
1. The Trump administration just handed Wall Street some great news. During his testimony to the Senate Banking Committee, the Treasury Secretary said the Trump administration did not support the separation of investment banks and commercial banks.
2. The Trump administration formally launches NAFTA renegotiations. US Trade Representative Robert Lighthizer said via a letter to US lawmakers that he triggered a 90-day consultation period with Congress and the American public that would allow talks to begin after August 16.
3. The US dollar has officially given up all its post-election gains. The greenback climbed to a 13-year high after US President Donald Trump won the election in early November, but the index has been slowly giving up those gains over the past few months.
4. Brazilian markets got rocked after local newspaper O Globo reported that a recording existed of President Michel Temer approving a payment intended to make jailed former house speaker Eduardo Cunha remain silent in the country's biggest-ever graft investigation. Some analysts argue the latest allegations could lead to concerns about Brazil's overall economic agenda.
5. Walmart beats on earnings as online sales surge. America's largest brick-and-mortar retailer said gross merchandise volume in its e-commerce unit - the value of everything sold online - jumped by 69% compared with the same period last year.
6. Elon Musk admits that Tesla's stock is out of control. "I do believe this market cap is higher than we have any right to deserve," he said in an interview with The Guardian, pointing out his company produces just 1% of GM's total output. "We're a money losing company."
7. A $25 billion biotech's stock jumped after releasing promising data on its new cancer drugs. Incyte was up by as much as 8% on Thursday morning.
8. Initial jobless claims unexpectedly dropped. Claims, which count the number of people who applied for unemployment insurance for the first time, fell by 4,000 to 232,000.
ADDITIONALLY:
Americans have more debt than ever before - here's what it looks like.
There's one big reason the stock market is becoming Trump-proof.
Amazon has several hurdles to jump before it can enter pharmaceuticals.
The opening shots have been fired in the battle between Apple and China's most valuable company.
- I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
- Saudi Arabia wants China to help fund its struggling $500 billion Neom megaproject. Investors may not be too excited.
- Colon cancer rates are rising in young people. If you have two symptoms you should get a colonoscopy, a GI oncologist says.
- Catan adds climate change to the latest edition of the world-famous board game
- Tired of blatant misinformation in the media? This video game can help you and your family fight fake news!
- Tired of blatant misinformation in the media? This video game can help you and your family fight fake news!
- JNK India IPO allotment – How to check allotment, GMP, listing date and more
- Indian Army unveils selfie point at Hombotingla Pass ahead of 25th anniversary of Kargil Vijay Diwas